In this study, it was demonstrated that the inhibition of GSK3β greatly suppressed the invasiveness of NSCLC cells, regardless of the cancer type, and this result supports the prognostic value and tumor promoter role of GSK3β in lung cancer. The gene discussed is GSK3B; the disease is cancer.